\
&
Contact us
\
&
Contact us
Published on | 1 month ago
ProgrammesEIT Health (European Institute of Innovation and Technology) invites applications for funding innovative digital and AI-powered medical technologies.
In order for the project to be eligible, the consortium involved must be composed of at least two organisations from different countries, including a commercialising company. Proposed solutions must be digital or AI-enabled medical devices at Innovation Maturity Level 6 (IML), with the aim of reaching IML 7 by the project's conclusion.
EIT Health will provide funding of up to 50% of the total project budget, capped at €850,000 per project. The funding period can last up to 24 months, encompassing pivotal clinical studies, regulatory submissions, product finalisation, and market strategies.
This call closes on 6 May 2026. Interested participants can join an information session on 18 March at 12h and engage in an Open Q&A Session on 8 April and 22 April.
For more details on eligibility and the application process, interested parties can refer to the website of the call.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital Europe AI Continent Advanced Digital Skills Deployment: Best use of technologies
The following call topics under the Digital Europe programme are now open for submission: Apply AI: Piloting AI-based image screening in medical centres Digital solutions for regulatory compliance through data Advanced Digital Skills for AI Uptake in Health EdTech Accelerator Digital Skills and Jobs Platform: The National Coalitions for Digi... read more
The City of Hasselt took part in the ONELAB project (2022–2025) as an end user. The project was funded under Horizon Europe (HORIZON-CL3-2021-DRS-01-05) and focused on developing modular Rapid Response Mobile Laboratories (RRML). These laboratories are designed for rapid deployment in a variety of settings to support disease monitoring.
